Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Apotea AB (publ)OSTO:APOTEA +0.28%18 Median PS Value is kr0.00 as of Jul. 26, 2026. GuruFocus rates OSTO:APOTEA with a GF Score™ of 18/100. The stock has 1 warning sign investors should review. Among 262 Healthcare Providers & Services companies, Apotea AB (publ) ranks worse than 381679.01% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Apotea AB (publ)'s Median PS Value or its related term are showing as below:
OSTO:APOTEA's Price-to-Median-PS-Value is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.72 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
Apotea AB (publ) (OSTO:APOTEA) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Apotea AB (publ)'s Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
72.30
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apotea AB (publ) Median PS Value Related Terms
Apotea AB (publ) Median PS Value Historical Data
* Premium members only.
The historical data trend for Apotea AB (publ)'s Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apotea AB (publ) Median PS Value Competitor Comparison
For the Pharmaceutical Retailers subindustry, Apotea AB (publ)'s Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apotea AB (publ) Price-to-Median-PS-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Apotea AB (publ)'s Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Apotea AB (publ)'s Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.
Apotea AB (publ)'s Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr72.862.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apotea AB (publ) (OSTO:APOTEA) has a Median PS Value of kr0.00 as of Jul. 26, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Apotea AB (publ) and its competitors. According to the industry distribution chart, Apotea AB (publ) ranks #999999 out of 262 companies in the Healthcare Providers & Services industry.
Is Apotea AB (publ)'s Median PS Value too high?
Apotea AB (publ)'s current Median PS Value is kr0.00. Based on the distribution chart, Apotea AB (publ) ranks #999999 out of 262 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Apotea AB (publ) has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Apotea AB (publ)'s Median PS Value compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Apotea AB (publ) ranks #999999 out of 262 companies for Median PS Value. This places Apotea AB (publ) in the lower half of its industry. The industry median Median PS Value is 0.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Healthcare Providers & Services company?
The median Median PS Value among Healthcare Providers & Services companies is 0.72, based on 262 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Apotea AB (publ) and its competitors. For the Healthcare Providers & Services industry, the median Median PS Value is 0.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apotea AB (publ)'s current Median PS Value is kr0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apotea AB (publ) stock overvalued right now?
Apotea AB (publ) (OSTO:APOTEA) has a current Median PS Value of kr0.00. The current Median PS Value is kr0.00. Apotea AB (publ)'s overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Apotea AB (publ) (OSTO:APOTEA), the current Median PS Value is kr0.00 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
18GF Score
Get the complete analysis for OSTO:APOTEA
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:APOTEA has been successfully added to your 
